Laboratory Safety of Dupilumab in Patients Aged 6 to 11 Years with Severe Atopic Dermatitis: Results from a Phase 3 Clinical Trial

  • Amy Paller (Creator)
  • A. Wollenberg (Creator)
  • E. Siegfried (Creator)
  • Diamant Thaçi (Creator)
  • M. Cork (Creator)
  • Peter D. Arkwright (Creator)
  • Melinda J. Gooderham (Creator)
  • Xian Sun (Creator)
  • John T. O’Malley (Creator)
  • Faisal A. Khokhar (Creator)
  • Jignesh Vakil (Creator)
  • Ashish Bansal (Creator)
  • Karli Rosner (Creator)
  • B. Shumel (Creator)
  • Noah A. Levit (Creator)
  • Amy S. Paller (Creator)
  • Andreas Wollenberg (Creator)
  • Elaine Siegfried (Creator)
  • Michael J. Cork (Creator)
  • Peter D. Arkwright (Creator)



For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021
Date made available2021
PublisherAdis Journals

Cite this